Under construction – not a live service
Sign in

2024-518898-34-00RecruitingPhase 2/3

A clinical study is aimed at comparing the effectiveness of two types of cell therapy in treating anal fistulas associated with Crohn's disease.

Source: EU CTIS (euclinicaltrials.eu) · Last updated 11 Mar 2026

Next steps

Status (registry)
Recruiting
Phase (registry)
Phase 2/3
Study type
Interventional
Enrollment
48 (estimated)
First submitted
22 Jan 2025
Start date
21 Apr 2026
Lead sponsor
Uniwersytet Jagiellonski Collegium Medicum
EU CT number
2024-518898-34-00
EudraCT number
2022-003197-23

What you commit to

  • Study type: Interventional · Phase 2/3
  • Planned participants: 48
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with an anal fistula linked to Crohn's disease. It compares two types of cell therapy.

Age
18 years or older
Sex
Women and men can both join.
Disease stage
An anal, recto-cutaneous or recto-vaginal fistula related to Crohn's disease.

Main reasons for not taking part

  • Healthy volunteers cannot join.

Read by machine on 9 Nov 2026.

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Szpital Specjalistyczny Im. Ludwika Rydygiera W Krakowie Sp. z o.o.CracowPolandRecruiting
5 Wojskowy Szpital Kliniczny Z Poliklinika Samodzielny Publiczny Zaklad Opieki Zdrowotnej W KrakowieCracowPolandRecruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.